Skip to content

Ostomy Telehealth For Cancer Survivors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02974634
Acronym
PCORI
Enrollment
216
Registered
2016-11-28
Start date
2016-11-30
Completion date
2019-08-29
Last updated
2020-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colostomy Stoma

Keywords

Ileostomy

Brief summary

The purpose of this study is to test the benefits of an educational program, the Ostomy Self-Management Training (OSMT) program, for improving patient activation (preparedness to do self-care), self-efficacy (patients' ability to do self-care), knowledge of ostomy/urostomy self-care, quality of life, mood, use of medical services, and financial burden in patients with ostomies. The study will compare patients in the intervention (training) group and patients in the usual care group. Subjects' participation in this study is expected to last about 7 months. The PI plans to enroll up to 176 subjects at 3 hospitals (University of Pennsylvania, Yale University School of Nursing, and City of Hope in Los Angeles). All patient telehealth education will be coordinated by the University of Arizona in Tucson, Arizona.

Detailed description

Over one million individuals in the U.S. have ostomies. The American Cancer Society estimates 39,610 rectal cancer cases and 74,000 bladder cancer cases will be diagnosed in 2015. Of these, at least 30,000 will receive ostomies, and an additional unknown number due to gynecologic, other gastrointestinal tumors. The HRQOL impact is tremendous and greater than with many other cancer treatments. An ostomy is often a prolonged or lifelong disabling problem for cancer survivors. The adaptation period is quite variable. 18% of participants took at least one year, or never felt comfortable, in their ostomy care. Importantly, many patients cannot attend selfmanagement programs or patient groups for a myriad of reasons, including distance to travel, monetary outlays, comorbidities making travel difficult, or lack of access to transportation. In addition, a national shortage of OCNs means patients with an ostomy, whether newly placed or a long-term issue, receive little help. It is imperative to study interventions for these cancer survivors aimed to limit family financial burdens, decrease medical care use, and improve well-being. This study has the potential to improve health care outcomes for cancer survivors with ostomies by enhancing their knowledge of and self-efficacy with ostomy care. This will be accomplished by improving the ability to communicate an established educational curriculum developed based on patient needs and desires and refined via a pilot study.

Interventions

OTHEROstomy self management training

Ostomy Self management Training group in which subject will learn using pouches and equipment, skin care, ostomy complications, nutritional needs, Impact on feelings, clothing changes, social relationships, being prepared for emergencies, Intimacy and sexuality, communication skills, tips for travelling and physical activity recommendations

Sponsors

City of Hope Medical Center
CollaboratorOTHER
Yale University
CollaboratorOTHER
University of Arizona
CollaboratorOTHER
University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

* All cancer survivors over 21 years of age having undergone a procedure that needed an intestinal stoma (fecal or urinary).

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Patient Activation Measure (PAM), a 100 Point Scale Determining Patient Engagement in Healthcare.baseline, on completion of session ( 5 weeks) and 6 month follow upThe patient activation measure (PAM) is a 100-point, quantifiable scale determining patient engagement in healthcare. PAM uses a uni-dimensional, probabilistic Guttman-like scale that reflects a developmental model of activation involving four stages (see below). 0 indicates lower activation (worse) whereas 100 indicates higher activation (better) (1) believing the patient role is important, (2) having the confidence and knowledge necessary to take action, (3) actually taking action to maintain and improve one's health, and (4) staying the course even under stress.

Secondary

MeasureTime frameDescription
Self-Efficacy to Perform Ostomy Self-Management Behaviorsbaseline, on completion of session ( 5 weeks) and 6 month follow upModified from Lorig and colleagues' Self-Efficacy to Perform Self-management Behaviors Scale, an outcome measure for Chronic Disease Management Interventions, this scale represents 8 domains with reported Cronbach's alpha for original scales: physical activity, information seeking,support, communication with HC providers, ostomy management , social and recreational, symptom management, and depression. Range 1 to 10, where higher is better outcome

Countries

United States

Participant flow

Recruitment details

Participants were enrolled at three study sites through several mechanisms. These include identification of potential participants via institutional registry, records,databases.Referrals from site WOCNs, attending surgeons and other clinical providers; and through distribution of Institutional . Subjects were recruited from 11/01/16 to 10/01/2018.

Pre-assignment details

All cancer survivors over 21 years of age who were at least six weeks after a surgical procedure that necessitated the creation of an intestinal stoma (fecal or urinary) were recruited. Survivors with temporary ostomies were included, and there was no maximum time since surgery.

Participants by arm

ArmCount
Ostomy Self Management Training
Comparing OSMT group to UC group The intervention arm integrates goal setting and problem-solving approaches to enhance buy-in and encourage ability to carry out ostomy self-care. The curriculum was delivered via four group sessions by trained ostomy certified nurses and peer/experienced ostomates. An additional session was offered to support persons to address their needs related to ostomy care. Telehealth real-time videoconferencing was used to enhance program delivery to participants, usually in their homes, in three different geographic areas across two time zones. Ostomy Self management Training group in which subject will learn using pouches and equipment, skin care, ostomy complications, nutritional needs, Impact on feelings, clothing changes, social relationships, being prepared for emergencies, Intimacy and sexuality, communication skills, tips for travelling and physical activity recommendations
106
Usual Care
Comparing OSMT group to UC group Subjects were provided with physician and Wound ostomy nurses contacts and written information about an ostomy care. These study subject were expected only to complete study surveys.
110
Total216

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdvanced disease123
Overall StudyDeath811
Overall Studyintervention technology related issues50
Overall StudyNoncompliance37

Baseline characteristics

CharacteristicOstomy Self Management TrainingTotalUsual Care
Age, Continuous61.6 years61.6 years61.6 years
Ethnicity (NIH/OMB)
Hispanic or Latino
12 Participants20 Participants8 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
94 Participants196 Participants102 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Asian
6 Participants9 Participants3 Participants
Race (NIH/OMB)
Black or African American
10 Participants17 Participants7 Participants
Race (NIH/OMB)
More than one race
2 Participants5 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
11 Participants18 Participants7 Participants
Race (NIH/OMB)
White
76 Participants166 Participants90 Participants
Region of Enrollment
United States
106 participants216 participants110 participants
Sex: Female, Male
Female
50 Participants103 Participants53 Participants
Sex: Female, Male
Male
56 Participants113 Participants57 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
8 / 10611 / 110
other
Total, other adverse events
0 / 1060 / 110
serious
Total, serious adverse events
0 / 1060 / 110

Outcome results

Primary

Patient Activation Measure (PAM), a 100 Point Scale Determining Patient Engagement in Healthcare.

The patient activation measure (PAM) is a 100-point, quantifiable scale determining patient engagement in healthcare. PAM uses a uni-dimensional, probabilistic Guttman-like scale that reflects a developmental model of activation involving four stages (see below). 0 indicates lower activation (worse) whereas 100 indicates higher activation (better) (1) believing the patient role is important, (2) having the confidence and knowledge necessary to take action, (3) actually taking action to maintain and improve one's health, and (4) staying the course even under stress.

Time frame: baseline, on completion of session ( 5 weeks) and 6 month follow up

Population: Intent to treat participants who provided baseline and at least one followup measurement

ArmMeasureGroupValue (MEAN)Dispersion
Ostomy Self Management TrainingPatient Activation Measure (PAM), a 100 Point Scale Determining Patient Engagement in Healthcare.Baseline66.9 score on a scaleStandard Deviation 12.9
Ostomy Self Management TrainingPatient Activation Measure (PAM), a 100 Point Scale Determining Patient Engagement in Healthcare.Post session67.6 score on a scaleStandard Deviation 12.9
Ostomy Self Management TrainingPatient Activation Measure (PAM), a 100 Point Scale Determining Patient Engagement in Healthcare.6 months follow up70.7 score on a scaleStandard Deviation 13.3
Usual CarePatient Activation Measure (PAM), a 100 Point Scale Determining Patient Engagement in Healthcare.Baseline64.2 score on a scaleStandard Deviation 15.8
Usual CarePatient Activation Measure (PAM), a 100 Point Scale Determining Patient Engagement in Healthcare.Post session66.2 score on a scaleStandard Deviation 13.5
Usual CarePatient Activation Measure (PAM), a 100 Point Scale Determining Patient Engagement in Healthcare.6 months follow up66.5 score on a scaleStandard Deviation 12.3
p-value: 0.0695% CI: [-3.5, 5.6]t-test, 2 sided
Secondary

Self-Efficacy to Perform Ostomy Self-Management Behaviors

Modified from Lorig and colleagues' Self-Efficacy to Perform Self-management Behaviors Scale, an outcome measure for Chronic Disease Management Interventions, this scale represents 8 domains with reported Cronbach's alpha for original scales: physical activity, information seeking,support, communication with HC providers, ostomy management , social and recreational, symptom management, and depression. Range 1 to 10, where higher is better outcome

Time frame: baseline, on completion of session ( 5 weeks) and 6 month follow up

Population: Intent to treat participants who provided baseline and at least one followup measurement

ArmMeasureGroupValue (MEAN)Dispersion
Ostomy Self Management TrainingSelf-Efficacy to Perform Ostomy Self-Management BehaviorsBaseline6.7 score on a scaleStandard Deviation 2.1
Ostomy Self Management TrainingSelf-Efficacy to Perform Ostomy Self-Management BehaviorsPost session7.1 score on a scaleStandard Deviation 2
Ostomy Self Management TrainingSelf-Efficacy to Perform Ostomy Self-Management Behaviors6 months follow up7.3 score on a scaleStandard Deviation 2.2
Usual CareSelf-Efficacy to Perform Ostomy Self-Management BehaviorsBaseline7.0 score on a scaleStandard Deviation 2.2
Usual CareSelf-Efficacy to Perform Ostomy Self-Management BehaviorsPost session7.3 score on a scaleStandard Deviation 1.9
Usual CareSelf-Efficacy to Perform Ostomy Self-Management Behaviors6 months follow up7.1 score on a scaleStandard Deviation 2.1
p-value: 0.6895% CI: [-0.24, 0.91]t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026